Pharmaceutical cost containment and innovation in the United States
- 1 September 1997
- journal article
- Published by Elsevier in Health Policy
- Vol. 41, S71-S89
- https://doi.org/10.1016/s0168-8510(97)00048-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Risks, Regulation, and Rewards in New Drug Development in the United StatesRegulatory Toxicology and Pharmacology, 1994
- The Pharmaceutical Industry and Health Reform: Lessons From EuropeHealth Affairs, 1994
- Pricing, Profits, and Technological Progress in the Pharmaceutical IndustryJournal of Economic Perspectives, 1993
- New drug development in the United States from 1963 to 1990Clinical Pharmacology & Therapeutics, 1991
- Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing HomesNew England Journal of Medicine, 1991
- Impact of Managed Care On Prescription Drug UseHealth Affairs, 1991
- A Prescription for High Drug PricesHealth Affairs, 1990